• Summit Therapeutics (NASDAQ:SMMT) Earns "Buy" Rating from HC Wainwright

    المصدر: Buzz FX / 22 يناير 2025 01:50:17   America/Chicago


    Summit Therapeutics (NASDAQ:SMMT) Earns "Buy" Rating from HC Wainwright Written by MarketBeat January 22, 2025 Share Link copied to clipboard. HC Wainwright reissued their buy rating on shares of Summit Therapeutics ( NASDAQ:SMMT - Free Rep
    Read more...
شارك على،